Medical Research
(H30Z)
IRS Verified
DX Registered
990 on File
AMERICAN INSTITUTE FOR CANCER RESEARCH
Financial strength (30%)
76/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our Vision We want to live in a world where no one develops a preventable cancer. Our Mission We champion the latest and most authoritative scientific research from around the world on cancer prevention and survival through diet, weight and physical activity so that we can help people make informed lifestyle choices to reduce their cancer risk.
Financial Overview — FY 2025
$11.0M
Total Revenue
$12.0M
Total Expenses
$12.6M
Net Assets
31
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
66.7%
Fundraising Efficiency
N/A
Operating Reserve
12.62x
Liability-to-Asset
29.0%
Revenue Diversification
81.2%
Compared with Peers
FY 2025
Compared with 35 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
66.7% | 82.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.6% | 9.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.8% | 0.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
12.6 mo | 17.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
29.0% | 22.9% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
81.2% | 84.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
2.8% | 9.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
13.5% | 6.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-8.9% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $11.0M | $12.0M | $12.6M | 66.7% | 31 |
| 2024 | $10.7M | $10.6M | $13.3M | 62.0% | 41 |
| 2023 | $11.9M | $12.4M | $12.2M | 65.0% | 37 |
| 2022 | $14.5M | $13.7M | $12.1M | 66.1% | 44 |
| 2021 | $14.2M | $14.2M | N/A | — | 44 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.